Palantir Technologies' rich valuation is justified, and any long-term holders can still benefit from outsized returns. Click ...

Thoma Bravo is negotiating the terms of a potential deal with Verint (VRNT), which is working with an adviser, Bloomberg ...

JBS offers a 15% combined yield, strong growth potential, and US listing benefits. See here to know why it's rated a Buy for ...

Elon Musk oversees Tesla's US & Europe sales after exec departure, reshaping leadership amid sales slumps and declining ...

ServiceNow excels as a B2B software provider and has steadily grown revenues over the past decade. Find out why NOW stock is ...

Invesco Mortgage Capital is facing challenges with capital allocation and shareholder value. See why we have downgraded IVR ...

The Australian manufacturing sector is contracting further, as evidenced by the Ai Group Industry Index falling to ...

NYLI Cushing MLP Premier Fund (I shares) returned +5.38% for the quarter, delivering solid absolute performance while ...

Yext's bottom line is improving, but organic growth remains challenged. Click here to see why YEXT stock is a Hold.

U.S. Gold Corp.'s financial position is solid, with recent warrant exercises. Current valuation reflects much optimism. Read ...

Overweight position in the CMBS sector, particularly the AAA Agency subcomponent, was accretive to the NYLI Short Term Bond ...

Kura Oncology's ziftomenib shows promise in AML treatment, with FDA Priority Review ahead. Read here for an analysis of KURA ...